We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32.6B
AUM Growth
+$1.87B
(+6.1%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.96%
Top 10 Holdings %
Top 10 Hldgs %
9.03%
Holding
3,497
New
825
Increased
816
Reduced
580
Closed
693
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$213M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$183M |
| 3 |
Baxter International
BAX
|
+$173M |
| 4 |
3M
MMM
|
+$172M |
| 5 |
Analog Devices
ADI
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$197M |
| 2 |
TransDigm Group
TDG
|
+$181M |
| 3 |
Apple
AAPL
|
+$148M |
| 4 |
Oracle
ORCL
|
+$133M |
| 5 |
ACC
American Campus Communities, Inc.
ACC
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.6% |
| 2 | Technology | 10.81% |
| 3 | Financials | 10.76% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
P3 Health Partners Inc Warrant
PIIIW
$168K
| $248K | ﹤0.01% |
336,298
-183,085
| -35% | -$131K |
|
|
SUNL
2227
CALL
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $248K | ﹤0.01% |
+10,000
| New | +$642K |
|
|
HZNP
2228
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $248K | ﹤0.01% |
+4,000
| New | +$279K |
|
2229
Enbridge
ENB
$112B
| $247K | ﹤0.01% |
6,669
-123,535
| -95% | -$5.21M |
|
|
ITCI
2230
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $247K | ﹤0.01% |
+5,308
| New | +$277K |
|
2231
Lyell Immunopharma
LYEL
$347M
| $245K | ﹤0.01% |
+1,675
| New | +$227K |
|
2232
loanDepot
LDI
$320M
| $244K | ﹤0.01% |
+184,992
| New | +$304K |
|
|
MNTV
2233
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $240K | ﹤0.01% |
41,267
-299,759
| -88% | -$2.33M |
|
2234
Costamare
CMRE
$1.71B
| $239K | ﹤0.01% |
+26,728
| New | +$295K |
|
2235
TransAlta
TAC
$3.92B
| $239K | ﹤0.01% |
+27,038
| New | +$278K |
|
|
EVLVW
2236
DELISTED
Evolv Technologies Warrant
EVLVW
| $238K | ﹤0.01% |
500,000
| – | – |
|
2237
GFL Environmental
GFL
$14.7B
| $238K | ﹤0.01% |
9,426
-70,665
| -88% | -$1.95M |
|
2238
ImmunityBio
IBRX
$8.11B
| $238K | ﹤0.01% |
47,907
-17,038
| -26% | -$77.6K |
|
2239
Bank of Montreal
BMO
$129B
| $237K | ﹤0.01% |
2,708
-28,253
| -91% | -$2.73M |
|
2240
Hyatt Hotels
H
$16.8B
| $235K | ﹤0.01% |
+2,910
| New | +$247K |
|
|
SWAV
2241
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $235K | ﹤0.01% |
+846
| New | +$215K |
|
|
INCR
2242
Intercure
INCR
$57.1M
| $233K | ﹤0.01% |
+51,576
| New | +$281K |
|
2243
RPC Inc
RES
$1.4B
| $232K | ﹤0.01% |
33,406
-40,774
| -55% | -$296K |
|
2244
Parker-Hannifin
PH
$134B
| $231K | ﹤0.01% |
+954
| New | +$258K |
|
2245
Transocean
RIG
$6.39B
| $231K | ﹤0.01% |
93,596
-41,802
| -31% | -$134K |
|
2246
CALL
Antero Midstream
AM
$10.5B
| $230K | ﹤0.01% |
25,000
| – | – |
|
2247
British American Tobacco
BTI
$124B
| $230K | ﹤0.01% |
+6,487
| New | +$260K |
|
2248
FTI Consulting
FCN
$4.24B
| $229K | ﹤0.01% |
1,379
-6,113
| -82% | -$1.03M |
|
2249
Saia
SAIA
$10.1B
| $229K | ﹤0.01% |
1,207
-89,609
| -99% | -$19M |
|
2250
Repligen
RGEN
$9.45B
| $227K | ﹤0.01% |
+1,214
| New | +$256K |
|
Similar funds
BC
Balyasny Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Balyasny Asset Management held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Balyasny Asset Management deployed $3.25B of net new capital in Q3 2022, opening 825 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.
- Balyasny Asset Management's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
- Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
- Balyasny Asset Management's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
- Balyasny Asset Management fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
- Balyasny Asset Management's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
- Balyasny Asset Management opened 825 new positions and closed 693 in Q3 2022.
- Balyasny Asset Management's portfolio value rose 6.1% quarter-over-quarter to $32.6B.
Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.